Invo Bioscience News Today

By Josh Beckerman Shares of INVO BioScience, which is merging with NAYA Biosciences, rose 5% Tuesday after NAYA entered a binding term sheet to buy gene...

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […]

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 289,000 shares, an increase of 397.4% from the October 15th total of 58,100 shares. Based on an average daily volume of 1,840,000 shares, the short-interest ratio […]

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services company focused on expanding access to advanced fertility...

Shares of INVO Bioscience, Inc. (INVO) surged on a deal to buy NAYA Biosciences in an all-stock deal. INVO is currently trading at $2.8400, up $2.3000 or 425.

Breaking Stock News - INVO Bioscience (NASDAQ: INVO) and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...

Operator: Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode.

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with...

/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...